| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |